![]()  | |
| Legal status | |
|---|---|
| Legal status | 
  | 
| Identifiers | |
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C12H18BrNO2 | 
| Molar mass | 288.185 g·mol−1 | 
| 3D model (JSmol) | |
  | |
  | |
N-Ethyl-2C-B is a recreational designer drug with psychedelic effects.[1] It was first synthesised in the 1990s,[2] and was first identified as a new psychoactive substance in Finland in 2007.[3] It is specifically listed as an illegal drug in Finland,[4] and controlled under analogue provisions in a number of other jurisdictions.
See also
References
- ↑ Schifano F, Orsolini L, Papanti D, Corkery J (2017). "NPS: Medical Consequences Associated with Their Intake". Neuropharmacology of New Psychoactive Substances (NPS). Current Topics in Behavioral Neurosciences. Vol. 32. pp. 351–380. doi:10.1007/7854_2016_15. ISBN 978-3-319-52442-9. PMID 27272067.
 - ↑ Glennon RA, Dukat M, el-Bermawy M, Law H, De los Angeles J, Teitler M, King A, Herrick-Davis K (June 1994). "Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines". Journal of Medicinal Chemistry. 37 (13): 1929–35. doi:10.1021/jm00039a004. PMID 8027974.
 - ↑ "2007 Annual Report on the implementation of Council Decision 2005/387/JHA" (PDF). European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) & Europol.
 - ↑ "Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista" [Government Decree on Psychoactive Substances Banned from the Consumer Market]. Finlex Data Bank (in Finnish).
 
| Phenethylamines | 
 
 
 
 
  | 
|---|---|
| Amphetamines | 
  | 
| Phentermines | 
  | 
| Cathinones | 
  | 
| Phenylisobutylamines | |
| Phenylalkylpyrrolidines | |
| Catecholamines (and close relatives)  | 
  | 
| Miscellaneous | 
  | 
| Psychedelics (5-HT2A agonists)  | 
  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dissociatives (NMDAR antagonists)  | 
  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deliriants (mAChR antagonists)  | 
  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Others | 
  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
